Reports previously published suggest that serotonin metabolites are associated with the pathogenesis ofchorea (Faurbye, 1970; , but their precise role is yet to be established.
Conflicting reports have followed experiments using daily doses of tryptophan given orally. Oepen and Oepen (1969) found no deterioration in the motor performance of patients with Huntington's chorea given 10 g of L-tryptophan daily, while smaller doses given by Barbeau produced choreiform movements in patients with juvenile Huntington's disease and in other choreiform patients (Barbeau, 1969) . Another serotonin precursor, 5-hydroxy-tryptophan, given orally was said to aggravate the severity of choreiform movements in patients with Huntington's chorea (Lee, Markham, and Clark, 1967) . Oliphant, Evans, and Forrest using both tryptophan and 5-hydroxy tryptophan found no increase in abnormal movements. (Oliphant, Evans, and Forrest, 1960) .
In experimental animals choreiform movements can be produced by lesions to the serotoninergic pathways which originate in the dorsal and median raphe nuclei of the mesencephalon and ascend, in association with the medial forebrain bundle, to the corpus striatum, hypothalamus, thalamus and limbic system (Poirier and Sourkes, 1965; Aghajanian, Bloom, and Sheard, 1969) . Subsequently, the concentration of serotonin is decreased in the corpus striatum (Faurbye, 1970) . As a similar deficit of serotonin is found in the brain of patients with Huntington's chorea The scores used were the average number per minute of letters correctly cancelled (from two trials of 60 seconds per subject) and the total number of letters covered from the start of the page to the last cancellation mark.
2. BEAD AND TAPPER TEST In this test two component tasks were involved. One was to transfer beads, using a pair of tweezers, from a full cup to an empty one. Each subject used his preferred hand, 510 which in all cases but one (a patient with Huntington's chorea) was the right.
The second task was to tap a morse tapper as quickly as possible with the non-preferred hand (the left one except for the one patient mentioned).
A standard practice session was given before commencement of the experimental trials. There were two 60 second trials of each task combination: beads alone, tapping alone, beads and tapping simultaneously-with a change of hands when this task was repeated for the second time. Scores were the number of taps (recorded electrically) and the number of beads transferred into the empty pot and were the average of the two trials.
RESULTS
The change in the average score for all tasks from occasion 1 to occasion 2 was used as a measure of improvement. There was no significant difference between the control and the Huntington's disease group. The two groups, however, are not strictly comparable, for the initial scores of the control groups are much higher than those of the Huntington's disease group, although the improvement with practice is similar in both groups (see Table) . Carroll, Mowbray, and Davies (1970) (Paulson, 1971) and was included to ensure that some of the digested L-tryptophan became serotonin, since it is known that a diet poor in pyridoxine reduces considerably the serotonin levels in many tissues (Garattini and Valzelli, 1965 was then maintained for a further seven days after which a daily dose of 50 mg pyridoxine was added for another 14 days. No change in the tremor was reported in either of two patients. It would appear that large daily doses of tryptophan, or tryptophan and pyridoxine, or pyridoxine alone do not aggravate choreiform movements in patients with Huntington's chorea. These results do not agree with those of Barbeau (1969) , and are difficult to reconcile with those of Lee et al. (1967) .
Huntington's chorea is a progressive degenerative disease of the brain which is inherited as an autosomal dominant gene with complete penetrance (Bruyn, 1968 (Faurbye, 1970) . Poirier and Sourkes (1965) (Faurbye, 1970) .
The malfunction of the extrapyramidal system in Huntington's chorea may be due to disturbance of the balance between the excitatory compounds, acetylcholine and histamine (Barbeau, 1962) and serotonin and catecholamines, possibly inhibitory substances (Smythies, 1965) . The administration of L-dopa in Parkinson's disease may be associated with the production of choreiform movements as a side-effect, and the imbalance between these compounds, actual or relative, may be important aetiological factors.
Disturbances of dopamine metabolism have not been detected in cases of Huntington's chorea and Lee et al. (1967) and Barbeau (1969) have argued for the role of serotonin in the disorder. McNamee, Kelvin, and Turnbull (1971) have shown a urinary excretion of 5-hydroxyindoleacetic acid higher in a group of Huntington's patients than in a group of control subjects, and suggest that this lends support to Lee et al. The group of control subjects used, however, were hospitalized patients and both a nonhospitalized group and the Huntington's chorea group of patients showed similar levels. Klawans, Ilahi, and Shenker (1970) believe that the lesion of Huntington's chorea is such that the striatal cells become abnormally sensitive to the normal release of neurotransmitters. They state 'it is clear that giving patients with Huntington's chorea the precursors of the putative neurotransmitter increases the involuntary movements'. With respect to tryptophan, our observations do not support this assertion.
